3-(((tert-Butyldimethylsilyl)oxy)methyl)-5-methoxypyridine

Catalog No. :
ACSZOW547
CAS No. :
1045855-62-6
Molecular Formula :
C13H23NO2Si
Molecular Weight :
253.42

IUPAC Name:3-(((tert-butyldimethylsilyl)oxy)methyl)-5-methoxypyridine

3-(((tert-Butyldimethylsilyl)oxy)methyl)-5-methoxypyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$111.00Login to see priceInquiryInquiry
250mg95%$255.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(((tert-Butyldimethylsilyl)oxy)methyl)-5-methoxypyridine
IUPAC Name3-(((tert-butyldimethylsilyl)oxy)methyl)-5-methoxypyridine
MDL No.MFCD11052850
Molecular FormulaC13H23NO2Si
Molecular Weight253.42
SMILESCOC1=CN=CC(CO[Si](C)(C(C)(C)C)C)=C1
InChI KeyQZZNOAMEUXEYKS-UHFFFAOYSA-N
SynonymDTXSID00670126 | 3-({[tert-Butyl(dimethyl)silyl]oxy}methyl)-5-methoxypyridine | CS-0440454 | VRB85562 | FT-0755336 | 3-((tert-Butyldimethylsilyloxy)methyl)-5-methoxypyridine | 3-((tert-Butyldimethylsilyloxy)methyl)-5-methoxypyridine, AldrichCPR | tert-but
CAS No.1045855-62-6
PubChem CID45361745

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACSZOW547 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Then
  5. ACSZOW547 route product structure diagram
    ACSZOW5471045855-62-6
Inquiry

2. ACSZOW547 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSZOW547 route product structure diagram
    ACSZOW5471045855-62-6
Inquiry

Comments (0)